Clinical Trials on Arteriovenous Graft in New Zealand
Total 221 results
-
ShireTerminated
-
VentureMed Group Inc.RecruitingArterial Occlusive Diseases | Fistula | Arteriovenous Fistula | Arteriovenous GraftUnited States
-
Medtronic EndovascularCompletedFistula | Arteriovenous Fistula | Arteriovenous Fistula Stenosis | Arteriovenous Fistula OcclusionNew Zealand, United States, Japan
-
MedtronicRecruitingFistula | Arteriovenous Fistula | Arteriovenous Fistula Stenosis | Arteriovenous Fistula OcclusionUnited States
-
Albany Medical CollegeWithdrawnPrimary Arteriovenous Fistula FailureUnited States
-
Columbia UniversityIncyte CorporationTerminatedGraft Vs Host Disease | Steroid Refractory GVHDUnited States
-
University of RochesterWithdrawnActive Chronic Graft Versus Host DiseaseUnited States
-
NYU Langone HealthRecruiting
-
NYU Langone HealthActive, not recruitingGraft-versus-host DiseaseUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingGraft-Versus-Host Disease | GVHD | UndefinedUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedGraft Versus Host DiseaseUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedGraft Versus Host DiseaseUnited States
-
Yale UniversityTerminatedGraft Versus Host DiseaseUnited States
-
University of RochesterTerminatedChronic Graft Versus Host DiseaseUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States, Canada, Australia, Switzerland, Puerto Rico, New Zealand
-
Mesoblast, Inc.No longer availableGraft-Versus-Host DiseaseUnited States
-
Northwell HealthWithdrawnAcute GVH DiseaseUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedGraft Versus Host Disease | Hematopoietic Cell Transplantation RecipientUnited States
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
VentureMed Group Inc.CompletedArteriovenous Fistula StenosisUnited States
-
NYU Langone HealthRecruitingGraft Vs Host DiseaseUnited States
-
Columbia UniversityCompletedImplant or Graft; RejectionUnited States
-
Alejandro BerensteinRecruitingIntracranial Arteriovenous Malformations | Arterio-venous FistulaUnited States
-
SoligenixTerminatedChronic Gastrointestinal Graft vs Host DiseaseUnited States
-
NYU Langone HealthCompleted
-
Regimmune CorporationCompletedGraft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Prevention of aGVHDUnited States
-
Roswell Park Cancer InstituteCompletedGraft Versus Host DiseaseUnited States
-
Genentech, Inc.TerminatedAcute Graft-versus-host DiseaseUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Hackensack Meridian HealthTerminatedGraft Versus Host DiseaseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Far Eastern Memorial HospitalRecruiting
-
Genentech, Inc.Completed
-
C. R. BardRecruitingArteriovenous FistulaUnited States, Canada
-
St. Luke's-Roosevelt Hospital CenterCompletedBrain Arteriovenous Malformation | Brain Vascular Malformations | Vein of Galen MalformationUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
MallinckrodtParexelCompletedChronic Graft Versus Host DiseaseUnited States, France, Germany, United Kingdom, Spain, Italy, Austria, Hungary
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
NovartisCompletedKidney Transplantation | Graft RejectionUnited States
-
Englewood Hospital and Medical CenterWithdrawnArteriovenous Access Fistula StenosisUnited States
-
John LevineCompletedGVHD | Low Risk Acute Graft-versus-host Disease | Graft-versus-host-diseaseUnited States
-
EVIVE BiotechnologyMemorial Sloan Kettering Cancer CenterCompletedAcute Graft vs Host DiseaseUnited States
-
The University of QueenslandBaxter Healthcare Corporation; Health Research Council, New Zealand; Australian...CompletedEnd Stage Kidney Disease | Kidney Transplant; Complications | Delayed Graft FunctionAustralia, New Zealand
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedGraft Rejection | Kidney FailureUnited States, Spain, Canada, Switzerland, Austria, Australia, New Zealand
-
Memorial Sloan Kettering Cancer CenterCompletedCD34 Selected Peripheral Blood Stem Cell GraftUnited States